Patient (n = 10) demographics and baseline characteristics*
| Baseline characteristics | Value |
| Age at screening (years) | |
| Mean (SD) | 61.5 (10.0) |
| Median | 59.5 |
| Minimum, maximum | 50, 78 |
| Sex, n (%) | |
| Male | 8 (80) |
| Female | 2 (20) |
| Race, n (%) | |
| Black or African-American | 1 (10) |
| White | 9 (90) |
| Ethnicity, n (%) | |
| Non-Hispanic/Latino | 10 (100) |
| Comorbidities at baseline, n (%) | |
| Hypertension | 10 (100) |
| Obesity | 8 (80) |
| Hyperlipidaemia | 5 (50) |
| Other cardiac disorders (CHF, CAD) | 3 (30) |
| Upper gastrointestinal disorders | 2 (20) |
| Depression | 2 (20) |
| Anxiety | 2 (20) |
| Moderate renal disease† | 2 (20) |
| Diabetes | 1 (10) |
| Duration of gout (years) | |
| Mean | 13 |
| Minimum, maximum | 3, 26 |
| Tophi in ⩾1 joint, n (%) | 5 (50) |
| Weight (kg) | |
| Mean (SD) | 105.3 (20.0) |
| Median | 107.6 |
| Minimum, maximum | 62.6, 131.5 |
| Height (cm) | |
| Mean (SD) | 171.2 (10.6) |
| Median | 170.2 |
| Minimum, maximum | 156.3, 187.2 |
*All patients treated; †glomerular filtration rate (GFR) 30–59 ml/min; patients with GFR <30 ml/min were excluded from the study.
CAD, coronary artery disease; CHF, congestive heart failure.